Human blood platelets are not aggregated by C5a-desArg. They are brought to aggregation, however, when human polymorphonuclear leukocytes (PMN) are present in the platelet suspension. Then, mixed aggregates form upon activation with C5a-desArg. The platelets do not adhere only to PMN but also stick to each other, indicating that they are activated. This is also evident from their morphology which shows pseudopod formation. The formation of mixed aggregates requires the presence of Ca2+ and Mg2+, it does not occur at temperatures below 20 °C. The results suggest that the platelets are activated indirectly, by a mediator released from the PMN upon stimulation with C5a-desArg. When mixed with platelets, PMN partially aggregate already upon addition of Ca2+. This effect is not seen in pure PMN suspensions. C5a-desArg causes additional aggregation which includes the platelets. The indirectly stimulated platelets in turn enhance the aggregation of the PMN in the mixtures incubated with C5a-desArg. This may cause a positive feedback.

Keywords:
Adult respiratory distress syndrome, C5a, Leukocytes, Platelets, Aggregation
This content is only available via PDF.
1991
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.